(Q35092969)

English

Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Naomi Schlesinger

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Marc De Meulemeester

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Andrey Pikhlak

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

A Eftal Yücel

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Dominik Richard

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Valda Murphy

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Udayasankar Arulmani

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Peter Sallstig

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Alexander So

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

25 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Arthritis Research and Therapy

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

R53

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

25 March 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1186/ar3297

0 references

The pathogenesis of bone erosions in gouty arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Interleukin-1 antagonism in acute gout: is targeting a single cytokine the answer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Use of "spydergrams" to present and interpret SF-36 health-related quality of life data across rheumatic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Use of canakinumab in the cryopyrin-associated periodic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Perceptions of disease and health-related quality of life among patients with gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Quality of life and quality of care for patients with gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Role of interleukin-1beta during pain and inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Developments in the scientific and clinical understanding of gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Clinical manifestations of hyperuricemia and gout.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Long-term cardiovascular mortality among middle-aged men with gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Overview of the management of acute gout and the role of adrenocorticotropic hormone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Diagnosis of gout.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Treatment of acute gout in hospitalized patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Therapeutic advances in gout.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Colchicine for acute gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Prevalence of comorbid conditions and prescription medication use among patients with gout and hyperuricemia in a managed care setting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Gout: new insights into an old disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Gout-associated uric acid crystals activate the NALP3 inflammasome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Diagnosis of gout: clinical, laboratory, and radiologic findings.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

C-reactive protein: a new risk assessment tool for cardiovascular disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Lumiracoxib in the treatment of osteoarthritis, rheumatoid arthritis and acute postoperative dental pain: results of three dose-response studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Gout: epidemiology and lifestyle choices.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Management of acute and chronic gouty arthritis: present state-of-the-art

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

9 July 2018

The mechanism of osteoclast differentiation induced by IL-1.

1 reference

https://api.crossref.org/works/10.1186%2FAR3297

21 January 2018

Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography.

1 reference

https://api.crossref.org/works/10.1186%2FAR3297

21 January 2018

Quality of life and disability in patients with treatment-failure gout.

1 reference

https://api.crossref.org/works/10.1186%2FAR3297

21 January 2018

The economic burden of gout on an employed population.

1 reference

https://api.crossref.org/works/10.1186%2FAR3297

21 January 2018

Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans.

1 reference

https://api.crossref.org/works/10.1186%2FAR3297

21 January 2018

The disutility of chronic gout

1 reference

https://api.crossref.org/works/10.1186%2FAR3297

21 January 2018

Dietary risk factors for rheumatic diseases

1 reference

https://api.crossref.org/works/10.1186%2FAR3297

21 January 2018

Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial

1 reference

https://api.crossref.org/works/10.1186%2FAR3297

21 January 2018

Outcome domains for studies of acute and chronic gout

1 reference

https://api.crossref.org/works/10.1186%2FAR3297

21 January 2018

Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1186%2FAR3297

21 January 2018

Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132043

27 September 2018

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1186%2FAR3297

21 January 2018

Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: Fibroblast-mediated pathologic bone resorption

1 reference

https://api.crossref.org/works/10.1186%2FAR3297

21 January 2018

Is gout associated with reduced quality of life? A case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21439048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Independent impact of gout on mortality and risk for coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21439048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-reactive protein levels are influenced by common IL-1 gene variations

1 reference

https://pubmed.ncbi.nlm.nih.gov/21439048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21439048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21439048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/21439048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multi-centre, double-blind comparative study of the efficacy and safety of aceclofenac and diclofenac in the treatment of rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21439048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout

1 reference

https://pubmed.ncbi.nlm.nih.gov/21439048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35092969&oldid=1969456202"